Bioprocess Analyzers Market Size (2024 - 2029)

The bioprocess analyzers market is projected to experience significant growth over the forecast period, driven by an increasing demand for advanced medicines and biologics. The market's expansion is supported by the rising interest in vaccine production and biopharmaceuticals, particularly in response to global vaccination efforts and investments. The development of drug delivery systems for biologics and the growing geriatric population are also key factors contributing to market growth. Despite these positive trends, challenges such as the high cost of raw materials and issues with small-sized bioprocessing equipment may hinder market expansion.

Market Size of Bioprocess Analyzers Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Bioprocess Analyzers Market
Study Period 2019 - 2029
Market Size (2024) USD 2.00 Billion
Market Size (2029) USD 4.17 Billion
CAGR (2024 - 2029) 15.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Bioprocess Analyzers Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Bioprocess Analyzers Market Analysis

The Bioprocess Analyzers Market size is estimated at USD 2 billion in 2024, and is expected to reach USD 4.17 billion by 2029, growing at a CAGR of 15.80% during the forecast period (2024-2029).

The pandemic had an effect on the market studied. Factors such as high titer, constant product quality, the robustness of the process, fast turnaround times, and scalability are some of the reasons why bioprocess containers are being used in vaccine production. There are many companies whose products are being used for COVID-19 vaccine research. With the large-scale vaccination programs around the world and the new investments in the biopharmaceutical industry, the market studied is expected to regain its potential over the years.

The major factors attributed to the growth of the market are the growing interest in the development of advanced medicines and vaccines and the increasing demand for biologics. These factors are expected to increase the market's growth. The rising geriatric population is susceptible to chronic diseases, which is increasing the demand for biologics. Cardiovascular disease is one of the leading causes of death globally, in which myocardial infarction (MI) is a major event. According to the article published in March 2021 by the National Library of Medicine, current therapies do not adequately address the multiple dysregulated systems following MI. The research to develop drug delivery systems for biologics is expected to increase over the forecast period, positively impacting the growth of the market. The increasing investments by the major market players in the development of biologics are driving the market's growth. In 2022, Aurobindo Pharma (CuraTeQ Biologics) planned to invest around INR 300 crore in capacity expansion of biologics manufacturing facilities, and this facility is likely to be fully operational by 2026. Furthermore, biologics is efficient in treating rheumatoid arthritis and Crohn's disease, which may lead to the growth of bioprocess analyzers in the production process of biological products. Thus, the aforementioned factors are expected to increase the market's growth during the forecast period.

However, difficulties faced during the upstream and downstream process due to the small-sized bioprocessing equipment and the relatively high cost of the raw materials are constraints to the growth of the market.

Bioprocess Analyzers Industry Segmentation

As per the scope of the report, bioprocess is a technique used to produce biological products, such as microbial genetic strain, and commercially useful chemicals through a biological process. 

The bioprocess analyzers market is segmented by product (instruments and consumables), application (antibiotics, recombinant proteins, biosimilars, and other applications), type (substrate analysis, metabolite analysis, and concentration detection), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.

By Product
Instruments
Consumables
By Application
Antibiotics
Recombinant Proteins
Biosimilars
Other Applications
By Type
Substrate Analysis
Metabolite Analysis
Concentration Detection
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Bioprocess Analyzers Market Size Summary

The bioprocess analyzers market is poised for significant growth, driven by the increasing demand for advanced medicines and biologics. The market is experiencing a resurgence due to the heightened interest in vaccine production and the biopharmaceutical industry's expansion following the pandemic. Factors such as high titer, consistent product quality, and scalability are pivotal in the adoption of bioprocess containers, particularly in vaccine manufacturing. The rising geriatric population and the prevalence of chronic diseases are further propelling the demand for biologics, which in turn is expected to bolster the market for bioprocess analyzers. Investments by major players in biologics development and the strategic collaborations among companies are also contributing to the market's upward trajectory.

North America is anticipated to maintain a substantial share of the bioprocess analyzers market, supported by strategic initiatives and partnerships aimed at enhancing vaccine production capabilities. The region's market growth is further fueled by the establishment of manufacturing facilities and the expansion of production lines for bioprocessing systems. The market is moderately competitive, with key players like F. Hoffmann-La Roche AG, Nova Biomedical Corporation, and Thermo Fisher Scientific leading the charge. Innovations such as the CrisBio technology platform and collaborations for automated bioprocess monitoring solutions are indicative of the dynamic developments within the industry. These factors collectively underscore the market's potential for robust growth over the forecast period.

Explore More

Bioprocess Analyzers Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Interest in the Development of Advanced Medicines and Vaccines

      2. 1.2.2 Increasing Demand for Biologics

    3. 1.3 Market Restraints

      1. 1.3.1 Complexity of Upstream and Downstream Processing and Strict Regulations

      2. 1.3.2 High Cost of Raw Materials

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Instruments

      2. 2.1.2 Consumables

    2. 2.2 By Application

      1. 2.2.1 Antibiotics

      2. 2.2.2 Recombinant Proteins

      3. 2.2.3 Biosimilars

      4. 2.2.4 Other Applications

    3. 2.3 By Type

      1. 2.3.1 Substrate Analysis

      2. 2.3.2 Metabolite Analysis

      3. 2.3.3 Concentration Detection

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Bioprocess Analyzers Market Size FAQs

The Bioprocess Analyzers Market size is expected to reach USD 2.00 billion in 2024 and grow at a CAGR of 15.80% to reach USD 4.17 billion by 2029.

In 2024, the Bioprocess Analyzers Market size is expected to reach USD 2.00 billion.

Bioprocess Analyzers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)